Cell and tumour biology of the gastric enterochromaffin-like cell

Italian Journal of Gastroenterology and Hepatology

Volumn 31, Issue 7 SUPPL. 2, 1999, Pages

  Modlin, I M ^a   Tang, L H ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

ECL; Gastrin; Mastomys; Proliferation

Indexed keywords

GASTRIN;

CARCINOID; CELL TRANSFORMATION; CONFERENCE PAPER; ENTEROCHROMAFFIN CELL; EXPERIMENTAL MODEL; GENETIC PREDISPOSITION; HYPERGASTRINEMIA; MULTIPLE ENDOCRINE NEOPLASIA; RODENT; STOMACH CANCER;

ANIMALS; APOPTOSIS; CARCINOID TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CYTOPLASM; ENTEROCHROMAFFIN-LIKE CELLS; GASTRIC MUCOSA; GASTRINS; HISTAMINE RELEASE; HISTIDINE DECARBOXYLASE; HUMANS; IMMUNOHISTOCHEMISTRY; RATS; RECEPTORS, GROWTH FACTOR; RODENTIA; SENSITIVITY AND SPECIFICITY; SOMATOSTATIN; STOMACH NEOPLASMS;

EID: 0032723924     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (97)

1. Capella C, Vassallo G, Solcia E. Light and electron microscopic identification of the histamine-storing agyrophil (ECL) cell in murine stomach and of its equivalent in other mammals. Z Zellforsch 1971;118:68-84
2. Borch K. Epidemiologic, clinicopathologic and economic aspects of gastroscopic screening of patients with pernicious anemia. Scand J Gastroenterol 1986;21:21-30.
3. Gilligan CJ, Lawton GP, Tang LH, West AB, Modlin IM, Gastric Carcinoid tumors: The biology and therapy of an enigmatic and controversial lesion. Am J Gastroenterol 1995;90:338-52.
4. Hirschowitz B, Griffith J, Pellegrin D, Cumings OW. Rapid regression of enterochromaffin-like cell gastric carcinoids in pernicious anemia after antrectomy. Gastroenterology 1992;102:1409-18.
5. Lehy T, Mignon M, Cardiot G, Elouaer-Blanc L, Ruszniewski P, Lewin MJM, et al. Gastric endocrine cell behaviour in Zollinger-Ellison syndrome patients upon long-term potent antisecretory treatment. Gastroenterology 1989;96:1029-40.
6. Modlin IM, Tang LH. The gastric enterochromaffin-like cell: an enigmatic cellular link (ECL). Gastroenterology 1996;111:783-810.
7. Håkanson R, Bottcher G, Ekblad E, Panula P, Simonsson M, Dohlsten M, et al. Histamine in the endocrine cells in the stomach. A survey of several species using a panel of histamine antibodies. Histochemistry 1986;86:5-17.
8. Håkanson R, Sundler F. The gastrin concept: The proposed mechanism behind the development of drug-induced gastric carcinoids. In: Håkanson R, Sundler F, editors. The stomach as an endocrine organ. Amsterdam: Elsevier Science Publisher. 1991; p. 449-60.
9. Prinz C, Kajimura M, Scott D, Mercier F, Helander H, Sachs G. Histamine secretion from rat enterochromaffin-like cells. Gastroenterology 1993;105:449-61.
10. Heidenhain R. Ueber die Pepsinsbildung in den Pylorusdrusen. Pflugers Archiv für die Gesamte Physiologie 1878;18:169-71.
11. Forssman W, Orci L, Fielet R, Renold A, Rouiller C. The endocrine cells in the epithelium of the gastrointestinal mucosa of the rat. An electron microscope study. J Cell Biol 1969;40:692-715.
12. Håkanson R, Owman C, Sporrong B, Sundler F. Electron microscopic identification of the histamine-storing argyrophil (enterochromaffin-like) cells in the rat stomach. Z Zellforsch 1971;122:460-6.
13. Håkanson R, Oman C, Sjoberg N. Cellular stores of gastric histamine in the developing rat. Life Sci 1967;6:2535-43.
14. Solcia E, Capella C, Fiocca R, Cornaggia M, Bosi F. The gastroenteropancreatic endocrine system and related tumour. Gastroenterol Clin North Am 1989;18:671-93.
15. Solcia E, Fiocca R, Sessa F, Rindi G, Fianatti A, Cornaggia, M, et al. Morphology and natural history of gastric endocrine tumours. In: Håkanson R, Sundler F, editors. The stomach as an endocrine organ. Amsterdam: Elsevier Science Publisher; 1991. p. 473-98.
16. Håkanson R, Chen D, Andersson K, Monstein HJ, Zhao CM, Ryberg B, et al. The biology and physiology of the ECL cell. Yale J Biol Med 1994;67:123-34.
17. Rubin W, Schwartz B. Electronmicroscopic radioautographic identification of the ECL cell as the histamine-synthesizing endocrine cell of the rat stomach. Gastroenterology 1979;77:458-67.
18. Delwaide J, Belaiche J, Courtoy R, Vivario M, Louis E, Gast P, et al. Ultrastructural demonstration of histamine in human enterochromaffin-like cell granules. Gut 1991;32:834.
19. Håkanson R, Axelson J, Ihse I, Sundler F. The targets for the trophic action of gastrin and cholecystokinin. In: Håkanson, Sundler F, editors. The stomach as an endocrine organ. Amsterdam: Elsevier Science Publisher; 1991. p. 307-20.
20. Håkanson R, Larsson L, Liedberg G, Oscarson J, Sundler F, Vang J. Effects of antrectomy or portacaval shunting on the histamine storing endocrine-like cells in oxyntic mucosa of rat stomach. A fluorescence, histochemical, electron microscopic and chemical study. J Physiol 1967;259:785-800.
21. Sandvik AK, Lewin MJM, Waldum HL. Histamine release in the isolated vascularly perfused stomach of the rat: regulation by autoreceptors. Br J Pharmacol 1989;96:557-62.
22. Oettle AG. Spontaneous carcinoma of the glandular stomach in mastomys, an African rodent. Br J Cancer 1957;11:412-20.
23. Modlin IM, Zucker KA, Zdon MJ, Sussman J, Adrian TE. Characteristics of the spontaneous gastric endocrine tumour of Mastomys. J Surg Res 1988;44:205-15.
24. Suyama M, Saito T, Hara K, Kito H, Hosoda S. Production of serotonin by a transplantable strain of histamine-producing primary gastric carcinoid of Mastomys natalensis. J Natl Can Inst 1984;72:751-7.
25. Bilchilk AJ, Nilsson O, Modlin IM, Zucker KA, Adrian TE. Significance of gastric endocrine tumour and age-related gut peptide alterations in Mastomys. Reg Pept 1990;27:195-207.
26. Soll AH, Lewin KJ, Beaven MA. Isolation of histamine-containing cells from rat gastric mucosa: biochemical and morphologic difference from mast cells. Gastroenterology 1981;80:717-27.
27. Solcia E, Fiocca R, Villani L, Gianetti A, Cornaggia M, Chiaravalli A, et al. Morphology and pathogenesis of endocrine hyperplasias, precarcinoid lesions and carcinoids arising in chronic atrophic gastritis. Scand J Gastroenterol 1991;26(Suppl. 180):146-59.
28. Sachs G, Prinz C, Loo D, Bamberg LK, Besancon M, Shin J. Gastric acid secretion: Activation and inhibition. Yale J Biol Med 1994;67:81-95.
29. Dimaline R, Struthers J. Characterization of a vesicular monoamine transporter (VMAT2) from rat gastric corpus, and upregulation by achlorhydria. Gastroenterology 1995;108:A962.
30. De Giorgio R, Su D, Peter D, Edwards N, Brecha C, Sternini C. Vesicular monoamine transporter expression in enteric neurons and ECL cells. Gastroenterology 1995;108:A960.
31. Rangachari PK. Histamine: mercurial messenger in the gut. Am J Physiol 1992;262:G1-13.
32. Dimaline R, Sandvik AK. Histidine decarboxylase gene expression in rat fundus is regulated by gastrin. FEBS Letters 1991;281:20-2.
33. Sandor A, Kidd M, Lawton GP, Miu K, Tang LH, Modlin IM. Neurohormonal modulation of rat enterochromaffin-like cell histamine secretion. Gastroenterology 1996;110:1084-92.
34. Prinz C, Sachs G, Walsh JH, Coy DH, Wu SV. The somatostatin receptor subtype on rat enterochromaffin-like cells. Gastroenterology 1994;107:1067-74.
35. Tang LH, Lawton GP, Miu K, Modlin IM. Alteration of the gastrin/CCKB receptor by endogenous hypergastrinemia in transformed ECL cells. Gastroenterology 1995;108:A1011.
36. Nagata H, Matsui T, Ito M, Taniguchi T, Naribayashi Y, Arkima N, et al. Cloning and characterization of gastrin receptor from ECL carcinoid tumour of mastomys. Biochem Biophys Res Commun 1992;187:1151-7.
37. Andersson K, Chen D, Håkanson R, Mattsson H, Sundler F. Enterochromaffin-like cells in the rat stomach: Effect of α-FMH-evoked histamine depletion. A chemical, histochemical and electron microscopic study. Cell Tiss Res 1992;270:7-13.
38. Sandvik AK, Dimaline R, Marvik R, Brenna E, Waldum HL. Gastrin regulates histidine decarboxylase activity and mRNA abundance in rat oxyntic mucosa. Am J Physiol 1994;267:G254-8.
39. Viguera E, Trelles O, Urdiales J, Mates J, Jimenez-Sanchez F. Mammalian L-amino acid decarboxylases producing 1,4-diamines: analogies among differences. TIBS 1994;19:318-9.
40. Urdiales J, Mates J, Ninez de Castro I, Sanchez-Jimenez F. Chlorpheniramine inhibits the ornithine decarboxylase induction of Ehrlich carcinoma growing in vivo. FEBS Letters 1992;305:260-4.
41. Kubota H, Taguchi Y, Tohyama M, Matsuura N, Shiosaka S, Ishihara T, et al. Electron microscopic identification of histidine decarboxylase-containing endocrine cells of the rat gastric mucosa. Gastroenterology 1985;87:496-502.
42. Larsson H, Carlsson E, Mattson H, Lundell L, Sundler F, Sundell G, et al. Plasma gastrin and gastric enterochromaffin-like cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology 1986;90:391-9.
43. Chen D, Monstein HJ, Nylander AG, Zhao CM, Sundler F, Håkanson R. Acute responses of rat stomach enterochromaffin-like cells to gastrin: Secretory activation and adaptation. Gastroenterology 1994;107:18-27.
44. 2-receptor mediated feedback regulation of histamine release from endocrine cells in the rat stomach. J Physiol (Lond) 1978;276:151-7.
45. Dimaline R, Sandvik A, Evans D, Forster E, Dockray G. Food stimulation of histidine decarboxylase messenger RNA abundance in rat gastric fundus. J Physiol 1993;465:449-58.
46. Coffey RJ, Romano M, Polk WH, Dempsey PJ. Roles for transforming growth factor alpha in gastric physiology and pathophysiology. Yale J Biol Med 1995;65:693-704.
47. Polk WHJ, Dempsey PJ, Russell WE, Brown PI. Beauchamp RD, Barnard JA, et al. Increased production of TGF alpha following acute gastrin injury. Gastroenterology 1992;102:1467-74.
48. Reubi JC, Laissue J. Multiple actions of somatostatin in neoplastic disease. Trends Pharmacol Sci 1995;16:110-5.
49. Ito M, Matsui T, Taniguchi T, Tsukamoto T, Murayama T, Arima N. Functional characterization of a human brain cholecystokinin-B receptor. A trophic effect of cholecystokinin and gastrin. J Biol Chem 1993;268:18300-5.
50. Duan R-D, Williams JA. Cholecystokinin rapidly activates mitogen-activated protein kinase in rat pancreatic acini. Am J Physiol 1994;267:G401-8.
51. Lu L, Logsdon CD. CCK, bombesin, and carbachol stimulate c-fos, c-jun and c-myc oncogene expression in rat pancreatic acini. Am J Physiol 1992;263-G327-32.
52. 2-antagonist SK&F 93479 and+ oxmetidine and omeprazole. Toxicol Pathol 1988;16:288-98.
53. Havu N, Mattson H, Ekamn L, Carlsson E. Enterochromaffin-like cell carcinoids in the gastric mucosa following long-term administration of ranitidine. Digestion 1990;45:189-95.
54. Modlin IM, Tang LH, Lawton GP, Darr UM, Zhu ZH, Soroka CJ. Enterochromaffin-like cell pathobiology of mastomys. Ann NY Acad Sci 1994;733:365-79.
55. Håkanson R, Sundler F. Proposed mechanism of gastric carcinoids: The gastrin hypothesis. Eur J Clin Invest 1990;20:S65-71.
56. Tielemans Y, Willems G, Sundler F, Håkanson R. Self-replication of enterochromaffin-like cells in the mouse stomach. Digestion 1990;45:138-46.
57. Barrett P, Hobbs RC, Coates PJ, Risdon RA, Wright NA, Hall PA. Endocrine cells of the human gastrointestinal tract have no proliferative capacity. Histochem J 1995;27:482-6.
58. Derynck R. The physiology of transforming growth factor alpha. Adv Cancer Res 1992;58:27-52.
59. Rutten MJ, Dempsey PJ, Solomon TE, Coffey RJ. Transforming growth factor alpha is a potent mitogen for primary cultures of guinea pig gastric mucous epithelial cells. Am J Physiol 1993;265:G361-9.
60. Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Brigman TS, et al. Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res 1987;74:707-12.
61. Tang LH, Modlin IM, Lawton GP, Kidd M, Chinery R. The role of TGFα in the development of enterochromaffin-like (ECL) cell tumour autonomy in African rodent mastomys. Gastroenterology 1996;111:1212-23.
62. Di Fiore P, Pierce J, Fleming T, Hazan R, Ulrich A, King C, et al. Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell 1987;51:1063-70.
63. Di Marco E, Pierce J, Fleming T, Kraus M, Molloy C, Aaronson S, et al. Autocrine interaction between TGF alpha and the EGF-receptor: Quantitative requirements for induction of the malignant phenotype. Oncogene 1989;4:831-8.
64. Baserga R, The insulin-like growth factor I receptor: A key to tumour growth? Cancer Res 1995;55:249-52.
65. Coppola D, Ferber A, Miura M, Sell C, D'Ambrosio C, Rubin R, et al. A functional insulin-like growth factor-I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor. Mol Cell Biol 1995;14:4588-95.
66. Sell C, Dumenil G, Deveaud C, Miura M, Coppola D, De Angelis T, et al. Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts. Mol Cell Biol 1994;14:3604-12.
67. Rubin R, Baserga R. Insulin-like growth factor receptor. Its role in cell proliferation. Lab Invest 1995;73:311-31.
68. Resnicoff M, Coppola D, Sell C, Rubin R, Ferrone S, Baserga R. Growth inhibition of human melanoma cells in nude mice by an-tisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res 1994;54:4848-50.
69. Wright N. Trefoil peptides and the gut. Gut 1993;34:577-9.
70. Hoosein N, Thim L, Jorgensen K, Brattain M. Growth stimulatory effect of pancreatic spasmolytic polypeptide on cultured colon and breast tumor cells. FEBS Letters 1989;247:303-6.
71. Wright N, Poulsom R, Stamp G, Hall P, Jeffery R, Longcroft J, et al. Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol 1990;162:279-84.
72. Modlin IM, Basson M, Soroka C, et al. Ulcer-induced alterations in cell phenotype and matrix growth factor expression. Eur J Gastroenterol Hepatol 1993;5(Suppl.):59-67.
73. Smith A. The distribution of histamine in human gastric tissue. Clin Sci 1959;18:533-41.
74. Modlin IM, Kumar RR, Soroka CJ, Ahlman H, Nilsson O, Goldenring JR. Histamine as an intermediate growth factor in the genesis of gastric ECLomas associated with hypergastrinaemia in Mastomys. Dig Dis Sci 1994;39:1446-53.
75. Chuang CH, Chen MC, Soll AH. Gastrin-histamine interactions: direct and paracrine elements. Scand J Gastroenterol 1990;180:95-103.
76. Bartholeyns J, Bouclier M. Involvement of histamine in growth of mouse and rat tumors: Antitumoral properties of monofluoromethylhistidine, an enzyme activated irreversible inhibitor of histidine decarboxylase. Cancer Res 1984;44:639-45.
77. Fujimoto K, Imamura I, Granger N, Wada H, Sakata T, Tso P. Histamine and histidine decarboxylase are correlated with mucosal repair in rat small intestine after ischemia-reperfusion. J Clin Invest 1992;89:129-33.
78. Modlin IM, Zhu Z-H, Tang LH, Kidd M, Lawton GP, Miu K, Powers RE, et al. Evidence for a regulatory role for histamine in gastric enterochromaffin-like cell proliferation induced by hypergastrinemia. Digestion 1996;57:310-21.
79. Modlin IM, Miu KMK, Luque IA, Tang LH. identification of histamine-1 receptor subtype and determination of its function in enterochromaffin-like (ECL) cells. Gastroenterology 1996;110:A1101.
80. Brand SJ. Stone D. Reciprocal regulation of antral gastrin and somatostatin gene expression by omeprazole-induced achlorhydria. J Clin Invest 1988;82:1053-66.
81. Weckbecker G, Raulf F, Stolz B, Bruns C. Somatostatin analogues for diagnosis and treatment of cancer. Pharmacol Ther 1993;60:245-64.
82. Vidal C, Rauly I, Zeggari M, Delesque N, Esteve J-P, Saint-Laurent N, et al. Up-regulation of somatostatin receptors by epydermal growth factor and gastrin in pancreatic cancer cells. Mol Pharmacol 1994;46:97-104.
83. Liebow C, Reilly C, Serrano M, Serially AV. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc Natl Acad Sci 1989;86:2003-7.
84. Lee MT, Liebow C, Kamer AR, Shally AV. Effects of epidermal growth factor and analogues of luteinizing hormone-releasing hormone and somatostatin on phosphorylation and dephosphorylation of tyrosine residues of specific protein substrates in various tumors. Proc Natl Acad Sci 1991;88:1656-60.
85. Tsuzaki S, Moses AC. Somatostatin inhibits deoxyribonucleic acid synthesis induced by both thyrotropin and insulin-like growth factor-1 in FRTL5 cells. Endocrinology 1990;126:3131-38.
86. Reubi JC, Waser B, Horisberger U, Halter F, Soroka CJ, Kumar RR, et al. Identification of somatostatin and gastrin receptors on enterochromaffin-like cells from Mastomys gastric tumors. Endocrinology 1992;131:166-72.
87. Modlin IM, Kumar R, Soroka CJ, Pasikhov D, Nangia A, Goldenring JR. Gastrin-dependent inhibitory effects of octreotide on the genesis of gastric ECLomas. Surgery 1992;112:1048-56.
88. Ferraro G, Annibale B, Azzoni C, Marignani M, D'Ambra G, Feve D, et al. Octreotide therapy for ECL cell growth in atrophic gastritis. Gastroenterology 1995;108:A965.
89. Tang LH, Modlin IM. Somatostatin receptor regulation of gastric carcinoid tumors. Digestion 1996;57:11-14.
90. Reisine T, Kong H, Yano H, Takeda J, Bell G. Splice variant of the somatostatin receptor 2 subtype, somatostatin receptor 2B, couples to adenylyl cyclase. Mol Pharmacol 1993;44:1008-15.
91. Vanetti M, Vogt G, Hollt V. The two isoforms of the mouse somatostatin receptor (mSSTR2A and mSSTR2B) differ in coupling efficiency to adenylate cyclase and in agonist-induced receptor desensitization. FEBS Letters 1993;3:260-6.
92. Mahy N, Woolkalis M, Maning D, Reisine T. Characterization of somatostatin desensitization in the pituitary tumour cell line AtT-20. J Pharmacol Exp Ther 1988;247:390-6.
93. Sinicrope FA, Ruan SB, Clary KR, Sthephens LC, Lee JJ, Levin B. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 1995;55:237-41.
94. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994;266:1821-8.
95. Brito MJ, Williams GT, Thompson H, Fillipe MI. Expression of p53 in early (T1) gastric carcinoma and precancerous adjacent mucosa. Gut 1994;35:1697-700.
96. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell 1992;70:523-6.
97. Lane DP, Lu X, Hupp T, Hall PA. The role of the p53 protein in the apoptotic response. Phil Trans R Soc (Lond) 1994;345:277-80.